MAGE-A antigens as targets in tumour therapy

D.W. Meek, L. Marcar

    Research output: Contribution to journalArticlepeer-review

    77 Citations (Scopus)


    MAGE-A proteins constitute a sub-family of Cancer-Testis Antigens which are expressed mainly, but not exclusively, in germ cells. They are also expressed in various human cancers where they are associated with, and may drive, malignancy. MAGE-A proteins are highly immunogenic and are considered as potential targets for cancer vaccines and/or immuno-therapy. Moreover, recent advances in our understanding of their molecular pathology have revealed interactions that offer potential as therapeutic targets. Here we review recent progress in this area and consider how these interactions might be exploited, especially for the treatment of malignant cancers for which available treatments are inadequate.
    Original languageEnglish
    JournalCancer Letters
    Publication statusPublished - 1 Jan 2012


    Dive into the research topics of 'MAGE-A antigens as targets in tumour therapy'. Together they form a unique fingerprint.

    Cite this